Targeting tumor-resident mast cells for effective anti-melanoma immune responses.
Kaesler S, Wölbing F, Kempf WE, Skabytska Y, Köberle M, Volz T, Sinnberg T, Amaral T, Möckel S, Yazdi A, Metzler G, Schaller M, Hartmann K, Weide B, Garbe C, Rammensee HG, Röcken M, Biedermann T.
Kaesler S, et al.
JCI Insight. 2019 Oct 3;4(19):e125057. doi: 10.1172/jci.insight.125057.
JCI Insight. 2019.
PMID: 31578309
Free PMC article.